RxDoctor Payments Data

George Holmes, MD

Family Medicine · Nashville, TNNPI 1477548154

Payments from drug & device makers

$10,582in general payments, 2019–2025

Across 616 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • AstraZeneca$802
  • GSK$716
  • Novartis$512
  • plus $5K from 45 others

What the payments were for

  • Food & beverage$10,582100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,582 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$137,392
Medicare patients
300
Services billed
2,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin77$74,556
OzempicSemaglutide57$52,821
EliquisApixaban58$49,231
JanuviaSitagliptin Phosphate41$40,277
FarxigaDapagliflozin Propanediol20$22,724
TradjentaLinagliptin20$20,648
Breo ElliptaFluticasone/Vilanterol31$16,185
Atorvastatin Calcium688$9,697
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,553
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$9,214
SynjardyEmpagliflozin/Metformin Hcl12$5,725
Arnuity ElliptaFluticasone Furoate23$5,317
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$5,211
CelebrexCelecoxib11$4,978
Levothyroxine Sodium468$4,940

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Synjardy$390$100,929109 claims
PfizerEliquis, Celebrex$1,057$54,20869 claims
Novo NordiskOzempic$1,779$52,82157 claims
MerckJanuvia$203$40,27741 claims
GSKBreo Ellipta, Trelegy Ellipta, Arnuity Ellipta$716$31,05569 claims
AstraZenecaFarxiga$802$22,72420 claims
AbbVieSynthroid$428$2,33042 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →